LoginRegister

    Aleor Derma Karakhadi unit clears USFDA inspection

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  

    Mumbai: Drugmaker Alembic Pharma recently informed the bourses that its Joint Venture, Aleor Dermaceutical has successfully completed the US drug regulator's (USFDA) inspection.


    "Aleor Dermaceuticals Ltd. (Aleor Derma), a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; without any observations, " Alembic said.


    Also Read: Alembic Pharma clears USFDA inspection at Bioequivalence facility in Vadodara


    The inspection was carried out from 6th January 2020 to 8th January 2020, it added.


    Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. Alembic has a cumulative total of 110 Abbreviated New Drug Application (ANDA) approvals (97 final approvals and 13 tentative approvals) from USFDA.


    Also Read: Alembic Pharma JV Aleor gets tentative USFDA nod for therapeutic equivalent of Pennsaid Topical Solution

    AlembicAlembic PharmaAleor dermaGujaratinspectionOrbicularpharmapharma newsUSFDA

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X